The potential protective effects of malacca (Phyllanthus emblica L.) extract against doxorubicin-induced cardiotoxicity in male Wistar rats
Abstract
Doxorubicin as a chemotherapy agent is most widely used in cancer treatment. Long-term use at a predetermined dose has a side effect, namely cardiotoxicity. Doxorubicin-induced cardiotoxicity is considered to be caused by reactive oxygen species (ROS), which is also characterized by increasing CK-MB enzyme levels in the blood. To reduce the impact of doxorubin-induced toxicity, a study was conducted on natural antioxidant sources with cardioprotective capabilities in vivo. Phyllanthus emblica L. fruit was used as a sample for a natural source of antioxidants extracted using ethanol. Then performed a phytochemical screening of secondary metabolites contained in it. This extract was administered orally in various doses to the experimental animal Wistar rats and the induced doxorubicin to these animals. The CK-MB enzyme levels were measured, and the heart organ histopathology test was performed. The results of this study indicate that P. emblica L. fruit extract contains alkaloids, tannins, flavonoids, terpenoids, phenolics, and triterpenoids compounds. Extract treatment at a 400 mg/kg BW dose showed the best reduction in CK-MB levels with great improvements in regular arrangement and shape of myocardial muscle cells of cardiac tissue. The sample extract at a 400 mg/kg BW dose showed remarkably decreasing of CK-MB great improvements of heart tissue on doxorubicin-induced cardiotoxicity. This study showed the potential protective effect of P. emblica L. against doxorubicin-induced cardiotoxicity.
Keywords
References
Volkova M and Russell R 3rd. 2011. Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment. Curr. Cardiol. Rev. 7. 214–220.
Curigliano G et al. 2016. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management. CA. Cancer J. Clin. 66 309–325.
Dong J and Chen H. 2018. Cardiotoxicity of Anticancer Therapeutics. Front. Cardiovasc. Med. 5 2-8.
Ewer M S and Ewer, S M. 2015. Cardiotoxicity of anticancer treatments. .Nat. Rev. Cardiol. 12 547–558.
Mercuri V et al. 2016. Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs. J. Card. Fail. 22. 449–458.
Swain S M, Whaley F S and Ewer M. S. 2003. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 97 2869–2879.
Abdel-Daim M M, Kilany O E, Khalifa H A, and Ahmed A A M. 2017. Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis. Cancer Chemother. Pharmacol. 80 745–753.
Govender J, Loos B, Marais E, and Engelbrecht A-M. 2014. Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin. J. Pineal Res. 57 367–380.
Mitry M A, and Edwards J G. 2016. Doxorubicin induced heart failure: Phenotype and molecular mechanisms. Int. J. Cardiol. Hear. Vasc. 10 17–24.
Ewer M S and Ewer S M. 2010. Cardiotoxicity of anticancer treatments: what the cardiologist needs to know. Nat. Rev. Cardiol. 7 564–575.
Tremocoldi M A. 2018. Eploration of avocado by-products as natural sources of bioactive compounds. PLoS One. 13 e0192577.
Zhang, Y-Y, Yi M, and Huang Y. 2017. Oxymatrine ameliorates doxorubicin-induced cardiotoxicity in rats. Cell. Physiol. Biochem. 43 626–635.
Rahayu L E, Chiuman L, Ginting C N, and Ginting S F. 2020. Effects of Ethanolic Extract of Curcuma Longa on Cardiac Biomarkers of Doxorubicin-Induced Rats. Maj. Kedokt. Bandung. 52 199-204.
Al-Hadi H A and Fox K A. 2009. Cardiac markers in the early diagnosis and management of patients with acute coronary syndrome. Sultan Qaboos Univ. Med. J. 9 231–246.
Mythili S and Malathi N. 2015. Diagnostic markers of acute myocardial infarction. Biomed. reports. 3 743–748.
Lewandrowski K, Chen A, and Januzzi J. 2002. Cardiac markers for myocardial infarction. A brief review. Am. J. Clin. Pathol. 118 S93-S99.
Rahmani F, Najafizadeh P, Mousavi Z, Rastegar T, and Barzegar E. 2018. The protective effect of quercetin against hepatotoxicity induced by doxorubicin in male rats. Irianian J. Pharmaclol. 16 1–8.
M. Naz and N. Abbas. 2016. Study of Hepatoprotective effect produced by the fruits of Phyllanthus emblicus and silymarin against cisplatin induced hepatotoxicity. J. Pharm. Res. 10 1–7.
Salouege I et al. 2014. Means of evaluation and protection from doxorubicin‑induced cardiotoxicity and hepatotoxicity in rats. J. Cancer Res. Ther. 10 274–278.
Godghate A, and Sawant R. 2013. Qualitative phytochemical analysis of chloroform extract of leaves of Adhatoda vasica Nees. RASᾹYAN J. Chem. 6 107–110.
Edeoga H O, Okwu D E, and Mbaebie B O. 2005. Phytochemical constituents of some Nigerian medicinal plants. Afr. J. Biotechnol. 4 685–688.
Nurhasnawati H, Sundu R, Sapri S, Supriningrum R, Kuspradini H, and Arung E T. 2019. Antioxidant activity, total phenolic and flavonoid content of several indigenous species of ferns in East Kalimantan, Indonesia. Biodiversitas. 20 576–580.
Alabri T H A, Al-Musalami A H S, Hossain M A, Weli A M, and Al-Riyami Q. 2014. Comparative study of phytochemical screening, antioxidant and antimicrobial capacities of fresh and dry leaves crude plant extracts of Datura metel L. J. King Saud Univ. 26 237–243.
Sultana S, Ahmad S, Khan N, and Jahangir T. 2005. Effect of Emblica officinalis (Gaertn) on CCl4 induced hepatic toxicity and DNA synthesis in Wistar rats. Indian J. Exp. Biol. 43 430–436.
Jones W P, and Kinghorn A D. 2012. Extraction of plant secondary metabolites in Methods in biotechnology. Natural products isolation, 2nd ed. ( Totowa: Humana Press Inc.).
Pagare S, Bhatia M, Tripathi N, and Bansal Y K. 2015. Secondary metabolites of plants and their role: Overview. Curr. Trends Biotechnol. Pharm. 9 293–304.
Jassbi A R. 2006. Chemistry and biological activity of secondary metabolites in Euphorbia from Iran. Phytochemistry. 67 1977–1984.
Hussein R A. 2019. Plants secondary metabolites: The key drivers of the pharmacological actions of medicinal plants. Herbal Medicine. (Rijeka: IntechOpen) DOI: 10.5772/intechopen. 76139 .
Sriwatcharakul S. 2020. Evaluation of bioactivities of Phyllanthus emblica seed. Energy Rep. 6 442–447.
Luo W, Zhao M, Yang B, Ren J, Shen G, and Rao G. 2011. Antioxidant and antiproliferative capacities of phenolics purified from Phyllanthus emblica L. fruit.Food Chem. 126 277–282.
Chaphalkar R K, Apte G, Talekar Y, Ojha S K and Nandave M. 2017. Antioxidants of Phyllanthus emblica L. bark extract provide hepatoprotection against ethanol-induced hepatic damage: a comparison with silymarin. Oxid. Med. Cell. Longev. 2017 3876040.
Wang C C et al. 2017. Anti-inflammatory effects of Phyllanthus emblica L on benzopyrene-induced precancerous lung lesion by regulating the IL-1β/miR-101/Lin28B signaling pathway. Integr Cancer Ther. 16 505–515.
Mayachiew P, and Devahastin S. 2008. Antimicrobial and antioxidant activities of Indian gooseberry and galangal extracts. LWT 41 1153–1159.
Pientaweeratch S, Panapisal V, and Tansirikongkol A. 2016. Antioxidant, anti-collagenase and anti-elastase activities of Phyllanthus emblica, Manilkara zapota and silymarin: an in vitro comparative study for anti-aging applications. Pharm. Biol. 54 1865–1872.
Reddy A R N, Nagaraju J, Rajyalaksmi G, and Sarangapani M. 2012. Cardioprotective effect of N-(benzo[d]oxazol-2-yl)-2-(5-bromo-2- oxoindolin-3-ylidene)hydrazinecarbo xamide against doxorubicin induced cardiotoxicity in rats,” Toxicol. Environ. Chem. 94 2012–2018.
Gangarapu K. 2014. Cardioprotective activity of N’’,N’’’-bis[5-methyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene]carbonohydrazide derivative against doxorubicin induced cardiotoxicity in rats. J. Chem. 2014 1-7.
Alpsoy S et al. 2013. Antioxidant and anti-apoptotic effects of onion (Allium cepa) extract on doxorubicin-induced cardiotoxicity in rats. J. Appl. Toxicol. 33 202–208.
G. Singh et al. 2018. Protective effects of Terminalia arjuna against doxorubicin-induced cardiotoxicity. J. Ethnopharmacol. 117 123–129.
Sahyon H A and Al-Harbi S A. 2020. Chemoprotective role of an extract of the heart of the Phoenix dactylifera tree on adriamycin-induced cardiotoxicity and nephrotoxicity by regulating apoptosis, oxidative stress and PD-1 suppression. Food Chem. Toxicol. 135 111045.
Hao G, Yu Y, Gu B, Xing Y, and Xue M. 2015. Protective effects of berberine against doxorubicin-induced cardiotoxicity in rats by inhibiting metabolism of doxorubicin. Xenobiotica. 45 1024–1029.
Baniahmad B, Safaeian L, Vaseghi G, Rabbani M, and Mohammadi B. 2020. Cardioprotective effect of vanillic acid against doxorubicin-induced cardiotoxicity in rat. Res. Pharm. Sci. 15 87–96.
Abushouk A I, Ismail A, Salem A M A, Afifi A M, and Abdel-Daim M M. 2017. Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity. Biomed. Pharmacother. 90 935–946.
Warpe V S, Mali V R, Bodhankar A S S L, and Mahadik K R. 2015. Cardioprotective effect of ellagic acid on doxorubicin induced cardiotoxicity in wistar rats. J. Acute Med. 5 1–8.
Rashid S et al. 2013. Alleviation of doxorubicin-induced nephrotoxicity and hepatotoxicity by chrysin in Wistar rats. Toxicol Mech Methods. 23 337–345.
Seif H S A. 2016. Physiological changes due to hepatotoxicity and the protective role of some medicinal plants. Beni-Suef Univ. J. Basic Appl. Sci. 5 134–146.
Osataphan N, Phrommintikul A, Chattipakorn S C, and Chattipakorn N. 2020. Effects of doxorubicin-induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: Insights for future interventions. J. Cell. Mol. Med. 24 6534–6557.
Xin Y-F et al. 2007. Protective effect of Lycium barbarum on doxorubicin-induced cardiotoxicity. Phyther. Res. 21 1020–1024.
Karimi G, Ramezani M, and Abdi A. 2005. Protective effects of lycopene and tomato extract against doxorubicin-induced cardiotoxicity. Phyther. Res. 19 912–914.
Hijazi M A, Jambi H A, Aljehany B M, and Althaiban M A. 2019. Potential protective effect of Achillea fragrantissima against adriamycin-induced cardiotoxicity in rats via an antioxidant and anti-inflammatory pathway. Biomed Res. Int. 2019 1-10.
Ashour O M et al. 2011. Protective effect of bilberry (Vaccinium myrtillus) against doxorubicin-induced oxidative cardiotoxicity in rats. Med. Sci. Monit. 17 BR110–BR115.
Liu X et al. 2008. Identification of phenolics in the fruit of emblica (Phyllanthus emblica L.) and their antioxidant activities. Food Chem. 109 909–915.
Bandyopadhyay S K, Pakrashi S C, and Pakrashi A. 2000. The role of antioxidant activity of Phyllanthus emblica fruits on prevention from indomethacin induced gastric ulcer. J. Ethnopharmacol. 70 171–176.
Ruangchakpet A and Sajjaanantakul T. 2007. Effect of browning on total phenolic, flavonoid content and antioxidant activity in indian gooseberry (Phyllanthus emblica Linn.) Agric. Nat. Sci. 41 331–337.
Charoenteeraboon J, Ngamkitidechakul C, Soonthornchareonnon N, Jaijoy K, and Sireeratawong S. 2010. Antioxidant activities of the standardized water extract from fruit of Phyllanthus emblica Linn. Songklanakarin J. Sci. Technol. 32 599-604.
DOI: 10.24815/jn.v21i2.19699
Refbacks
- There are currently no refbacks.
Universitas Syiah Kuala (recognizedly abbreviated as